TU
ELV icon

TDAM USA’s Elevance Health ELV Stock Holding History

TDAM USA’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,625
Closed -$314K – 338
2014
Q3 		$314K Sell
2,625
-440
-14% -$50.5K 0.01% 273
2014
Q2 		$330K Sell
3,065
-735
-19% -$75.7K 0.01% 271
2014
Q1 		$378K Sell
3,800
-528
-12% -$47.8K 0.02% 267
2013
Q4 		$400K Buy
+4,328
New +$385K 0.02% 252
2013
Q3 		– Sell
-11,686
Closed -$899K – 310
2013
Q2 		$899K Buy
+11,686
New +$875K 0.04% 150

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

TDAM USA's ELV Position: Q4 2014 in Review

TDAM USA sold out of Elevance Health (ELV) in Q4 2014, closing a stake of 2,625 shares — an estimated $314K sold.

TDAM USA first reported a position in ELV in Q2 2013 and held it in 5 quarters. The position peaked at $899K in Q2 2013. 721 funds tracked by Wall St. Rank hold ELV as of Q4 2014.

  • TDAM USA reported no remaining Elevance Health position as of Q4 2014 after selling out during the quarter.
  • TDAM USA sold 2,625 Elevance Health shares in Q4 2014, an estimated $314K.
  • TDAM USA first reported a position in Elevance Health in Q2 2013 and held it in 5 quarters.
  • TDAM USA's Elevance Health position peaked at $899K in Q2 2013.
  • 721 funds tracked by Wall St. Rank held Elevance Health as of Q4 2014.

Based on TDAM USA's 13F filing for Q4 2014, filed 30 Jan 2015.